关注流式细胞术急性白血病免疫分型的难点与应对  

Pay attention to the difficulties of immunophenotyping of acute leukemia by flow cytometry and the countermeasures

作　　者：朱明清[1] 崔巍 Zhu Mingqing;Cui Wei(Jiangsu Institute of Hematology,the First Affiliated Hospital of Soochow University,National Clinical Research Center for Hematologic Diseases,NHC Key Laboratory of Thrombosis and Hemostasis,Suzhou 215006,China;State Key Laboratory of Molecular Oncology,Department of Clinical Laboratory,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China)

机构地区：[1]苏州大学附属第一医院,江苏省血液研究所,国家血液系统疾病临床医学研究中心,国家卫生健康委员会血栓与止血重点实验室,苏州215006 [2]国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院检验科,北京100021

出　　处：《中华检验医学杂志》2021年第12期1101-1104,共4页Chinese Journal of Laboratory Medicine

摘　　要：流式细胞术白血病免疫分型是目前急性白血病诊断与分型的主要方法。2016年修订的《造血与淋巴组织肿瘤分类》对评估急性白血病的诊断手段进行了改进。国内将这些有关急性白血病免疫分型的进展全面、规范化的运用到日常工作中尚存在难点和困惑, 亟待剖析和提出解决策略。Flow cytometric immunophenotyping of leukemia has been used as the main method of acute leukemia diagnosis and classification.The revised Classification of Hematopoietic and Lymphoid Tissue Tumors in 2016 improved the diagnostic method for acute leukemia assessment.In China,at present there are still difficulties in the large-scale application and the standardization of this new flow cytometric immunophenotyping of acute leukemia in daily work.A thorough analysis and solution is demanded.

关 键 词：急性白血病 流式细胞术 免疫分型 

分 类 号：R733.71[医药卫生—肿瘤]